Home

Wanbury Ltd PE Ratio

Image

Wanbury Ltd

NSE: WANBURY

PE

35.9

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Wanbury Ltd is 35.9 as of 22 Feb 11:55 AM .
  • The P/E Ratio of Wanbury Ltd changed from 0.7 on March 2020 to 8.5 on March 2024 . This represents a CAGR of 64.76% over 5 years.
  • The Latest Trading Price of Wanbury Ltd is ₹ 203.35 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Wanbury Ltd

No data available

Company Fundamentals for Wanbury Ltd

Image

Wanbury Ltd

NSE: WANBURY

Share Price

₹ 203.35

-6.45 (-3.07%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Wanbury Ltd

1M

1Y

3Y

5Y

Monitoring Wanbury Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025203.35
20 Feb 2025209.8
19 Feb 2025203.8
18 Feb 2025195.25
17 Feb 2025212.15
14 Feb 2025216.05
13 Feb 2025228.2
12 Feb 2025224.4
11 Feb 2025213.8
10 Feb 2025230.35

SWOT Analysis Of Wanbury Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Wanbury Ltd

Asset Value vs Market Value of Wanbury Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Wanbury Ltd666.39
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Wanbury Ltd Explained

666.39

Market cap

43

Earnings

35.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Wanbury Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Wanbury Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Wanbury Ltd

No data available

* All values are in %

About Wanbury Ltd

  • Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988.
  • The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.
  • In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga.
  • In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007.
  • Pursuant to the aforesaid Order of the Hon'ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008.

Wanbury Ltd News Hub

Wanbury consolidated net profit declines 77.83% in the June 2024 quarter

Net profit of Wanbury declined 77.83% to Rs 1.04 crore in the quarter ended June 2024 as against Rs

Read more

13 Aug 24

Wanbury to hold board meeting

Wanbury will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powered by C

Read more

08 Aug 24

Wanbury to conduct AGM

Wanbury announced that the 36th Annual General Meeting (AGM) of the company will be held on 27 Septe

Read more

11 Sept 24

Wanbury consolidated net profit rises 8.97% in the September 2024 quarter

Net profit of Wanbury rose 8.97% to Rs 8.02 crore in the quarter ended September 2024 as against Rs

Read more

14 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Wanbury Ltd

What is the current PE Ratio of Wanbury Ltd?

The Current PE Ratio of Wanbury Ltd is 35.93 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Wanbury Ltd last year?

The PE Ratio of Wanbury Ltd was 0.0 last year, now the PE ratio is 35.93, showing a year-on-year growth of -%.

What does the PE Ratio of Wanbury Ltd indicate about its stock?

The PE Ratio of Wanbury Ltd is 35.93. This ratio indicates that investors are willing to pay 35.93 times the earnings per share for each share of Wanbury Ltd.

What is the PE Ratio Growth of Wanbury Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Wanbury Ltd grew by -% whereas, the EPS ratio grew by -84.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions